| Adjunct
study | Clinical
study for silicone gel-filled breast implant to address a public health need for
reconstruction and revision patients. The status of the implants in an adjunct
study is investigational. |
| Asymmetry |
Uneven
appearance between a woman's breasts in terms of size, shape, or breast level. |
| Augmentation |
Includes
cosmetic uses, such as to increase breast size or for ptosis (sagging or drooping
of the breast) or asymmetry. Augmentation is one of three indications (clinical
uses) for breast implants. |
| Breast
pain | Pain
in the nipple or breast area. See the Local Complications & Reoperations
section for more details. |
| Breast
pocket | A
pocket surgically created to hold the implant. |
| Breast
tissue atrophy | Thinning
and shrinking of the skin. |
| Calcification/
calcium deposits | Hard
lumps under the skin around the implant. These can be mistaken for cancer
during mammography, resulting in additional surgery, either to biopsy the lumps
or to remove the implant. |
| Capsular
contracture | Scar
tissue or capsule that normally forms around the implant, which tightens or squeezes
the implant. There are four grades of capsular contracture ranging from
grade I (breast is normally soft and looks natural) to grade IV (breast is hard,
painful, and looks abnormal). See the Local Complications & Reoperations
section for more details. |
| Chest
wall deformity | When
the chest wall or underlying rib cage appears deformed following removal of the
implants and breast tissue. |
| Delayed
wound healing | Incision
site fails to heal normally or takes longer to heal. |
| Extracapsular
rupture | Rupture
of silicone gel-filled breast implant in which the silicone gel is outside of
the fibrous scar capsule that forms around the implant. |
| Extrusion |
Skin
breakdown with the implant appearing through the skin. |
| Galactorrhea |
Inappropriate
breast milk production that may occur after breast implant surgery. In some
cases, the milk production stops by itself or after receiving medicine to stop
milk production. In other cases, the implant(s) may need to be removed to
treat this complication. |
| Granuloma |
Non-cancerous
lumps that can form when certain body cells surround foreign material, such as
silicone. Like any lump, it should be evaluated to distinguish it from a
lump that might be cancerous. |
| Hematoma |
Collection
of blood inside a body cavity. Swelling, pain, and bruising may result.
If a hematoma occurs, it will usually be soon after surgery; however, it can also
occur at any time after injury to the breast. While the body absorbs small
hematomas, large ones may require the placement of surgical drains for proper
healing. A small scar can result from surgical draining. |
| Iatrogenic
injury/damage | Injury/damage
to the tissue or implant due to surgical instruments either during the operation,
during a reoperation, during implant removal, or during breast procedures while
the implant is in place (e.g., cyst aspiration or hematoma drainage). |
| Infection |
Can
occur with any surgery when wounds are contaminated with micro-organisms such
as bacteria or fungi. Most infections resulting from surgery appear within
a few days to weeks after the operation. However, infection is possible
at any time after surgery. Infections with an implant present are harder
to treat than infections in normal body tissues. If an infection does not
respond to antibiotics, the implant may have to be removed. Another implant
may be placed after the infection is gone. |
| Inframammary |
Within
the breast fold. |
| Inflammation/
irritation | Swelling
of the breast area, usually with redness. |
| Intracapsular
rupture | Rupture
of silicone gel-filled breast implant in which the silicone gel remains contained
within the fibrous capsule. |
| Investigational |
Not
approved, in general terms. For breast implants, this means not PMA-approved. |
| Investigational
Device Exemption (IDE) | Clinical
study performed to collect clinical data on a device to support approval of a
marketing application. Approval of an IDE study does not mean approval
to market the implant. The status of a device in an IDE study is investigational. |
| Local
complications | Complications
that occur in the breast or chest area. |
| Malposition/
displacement | When
the implant is placed incorrectly during the initial surgery or when the implant
has moved/shifted from its original position. Shifting can be caused by
many factors, such as gravity, trauma, poor initial placement, and capsular contracture. |
| Mastectomy |
Partial
or complete removal of the breast. |
| Mastopexy |
Surgical
procedure to raise and reshape sagging breasts. Women may also have this
surgery after an implant is removed and not replaced. |
| Necrosis |
Formation
of dead tissue around the implant. Factors associated with increased necrosis
include infection, use of steroids in the surgical breast pocket, smoking, chemotherapy/radiation,
and excessive heat or cold therapy. |
| Nipple/breast
sensation changes | An
increase or a decrease in the sensation in the nipple or breast. This change
can vary in degree and may be temporary or permanent. It may affect comfort
while nursing or sexual response. See the Local Complications & Reoperations
section for more details. |
| Palpability/
visibility | Palpability
is when the implant can be felt through the skin. Visibility is when the
implant can be seen through the skin, such as the valve on a saline-filled breast
implant or the edge of an implant. |
| Periareolar |
Around
the nipple. |
| Premarket
approval (PMA) | Application
for marketing a device. FDA must approve the PMA for the device to be sold
on the market in the U.S. |
| Prospective
study | Study
in which people are exposed to a medical intervention, such as breast implants,
and then observed over time to determine how effective and safe the intervention
is. The outcome is not known when a prospective study is started.
Medical evaluations are performed before and after the intervention so that the
outcome of the intervention can be measured. |
| Ptosis |
Sagging/drooping
of the breast. |
| Reconstruction |
Includes
non-cosmetic uses such as post-mastectomy, a severe injury to the breast, a birth
defect that affects the breast, or a medical condition causing a severe breast
abnormality. Reconstruction is one of three indications (clinical uses)
for breast implants. |
| Redness/
bruising | Bleeding
at operative site that causes discoloration and varies in degree and length of
time. This is expected following breast implant surgery or breast procedures. |
| Reduction
mammoplasty | Surgical
procedure to reduce breast size. |
| Removal
| Removal
of the implant, with or without replacement. See the Local Complications
& Reoperations section for more details. |
| Reoperation |
Any
additional surgery performed to the breast or chest area. See the Local
Complications & Reoperations section for more details. |
| Retrospective
study | Study
that begins after a medical intervention, such as breast implant surgery, has
occurred. Therefore, it looks backward in time at events complications that
happened in the past. For instance, a group of women with breast implants
may be identified and then asked to allow researchers to review their medical
records to obtain information on complications that they had. Women might
also be asked to respond to a survey or interview about whether or not they had
complications with their implants. The problem with this type of study is
that it assumes that if there was a problem, it would be in the medical record
or that someone would remember it accurately. |
| Revision |
This
is replacement of an existing breast implant. Revision is one of three indications
(clinical uses) for breast implants. |
| Rupture/
deflation | Hole
or tear in the shell of the implant that allows for loss of the filler material
from the shell. See the Local Complications & Reoperations section
for more details. |
| Scarring |
Formation
of tissue at the incision. All wounds heal by the formation of a scar. The
degree of scarring varies from person to person, and skin type is an important
factor for the development of scars. If the scarring becomes irregular and
raised, it is called hypertrophic scarring. This may leave a visible, permanent
scar. The keloid, a severe type of hypertrophic scar, generally does not
fade or flatten with time. |
| Seroma |
Collection
of the watery portion of the blood around the implant or around the incision.
Swelling, pain, and bruising may result. While the body absorbs small seromas,
large ones will require the placement of surgical drains for proper healing.
A small scar can result from surgical draining. |
| Silent
rupture | Rupture
of a silicone gel-filled breast implant that happens without a visible change
or feel by the woman and is not evident by a physical examination by the doctor. |
| Silicone |
Silicone
is a man-made material that can be found in several forms such as oil, gel, or
rubber (elastomer). The exact make-up of silicone will be different depending
on its use. See the Device Description section for more details.
|
| Subglandular |
When
the implant is placed under and within the breast glands but on top of the chest
muscles. |
| Submuscular |
When
the implant is placed underneath the chest muscles. |
| Toxic
Shock Syndrome | Rare,
but life-threatening bacterial infection that may occur after surgery. Symptoms
include sudden fever, vomiting, diarrhea, fainting, dizziness, and sunburn-like
rash. A doctor should be seen immediately for diagnosis and treatment
if toxic shock syndrome is suspected. |
| Transaxillary |
Under
the arm. |
| Unsatisfactory
style/size | Patient
or doctor is not satisfied with the overall look based on the style or size of
implant used. |
| Wrinkling/
rippling | Wrinkling
of the implant that can be felt or seen through the skin. |